COI.
search Request for Consideration arrow_forward menu
close Submit Innovation
close
Healthcare & Life Sciences verified Verified Outcome TRL 9

Smart Inhalers & Respiratory IoT

domain Client: A global pharmaceutical company handshake Provider: AWS IoT / Serverless schedule Deploy: 2022
85 Impact
Enterprise Ready
Evidence Score: A/10
Strength: High

Executive Summary

ANALYST: COI RESEARCH

Development of a digital health platform to ingest telemetry from smart inhalers, improving adherence and providing objective data to clinicians.

rate_review Analyst Verdict

"Medium Risk. The complexity lies in data privacy and device connectivity, but the shift from 'molecule provider' to 'outcome provider' is strategically sound."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Asthma and COPD management relies on patient adherence, which is notoriously poor and difficult to track. Clinicians lacked objective data on whether medication was taken effectively.

psychology The Solution

Launched the Digihaler® portfolio with built-in Bluetooth sensors. Built a backend on AWS using IoT Core and Lambda to securely ingest usage data and visualize it for patients and doctors.

settings_suggest Technical & Deployment Specs

Integrations
Mobile App / AWS
Deployment Model
Serverless
Data Classification
PHI / Device Telemetry
Estimated TCO / ROI
Scale-dependent
POC Summary ( to )

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Data Privacy / Consent High Strict user consent flows

trending_up Impact Trajectory

Audited value realization curve

FDA-cleared digital inhaler portfolio Verified Outcome
Primary KPIIngests millions of data points from devices
Audit CycleObjective insight into inspiratory flow rates

policy Compliance & Gov

  • Standards: HIPAA / FDA / GDPR
  • Maturity (TRL): 9
  • Evidence Score: A/10
  • Data Class: PHI / Device Telemetry

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock

Related Intelligence

article
Institutional Trading Platform API
View Outcome →
article
AI-Powered Dyslexia Support
View Outcome →
article
Generative AI for Interactive Content
View Outcome →
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for A global pharmaceutical company without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-494
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-494

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.